Evolution of the Average Target: LB Pharmaceuticals Inc

Evolution of the Average Target - LB Pharmaceuticals Inc

Evolution of the Target Price: LB Pharmaceuticals Inc

Evolution of the Target Price - LB Pharmaceuticals Inc

Changes in Analyst Recommendations: LB Pharmaceuticals Inc

d7c40f9.piA77AAK0PJqu2aFb53OlpeYqn5Y490SSejtRTIT-rM.7GJ3tHB5oZYI_FbSJ_u-5cLS6Rgum7ZRKr2JFWInzoDHeha_ZFy9ly_CDQ~8910284ad9bcef2e617d042a71aba99f

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+49.29%
+43.71%
+19.51%
+11.58%
+20.93%
+26.88%
+30.99%
+70.4%
+20.93%
+37.4%
Average +33.16%
Weighted average by Cap. +30.34%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
38.85USD
Average target price
58.00USD
Spread / Average Target
+49.29%
High Price Target
80.00USD
Spread / Highest target
+105.92%
Low Price Target
35.00USD
Spread / Lowest Target
-9.91%

Analyst Consensus Detail

Analyst consensus - LB Pharmaceuticals Inc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - LB Pharmaceuticals Inc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
MarketScreener Ratings - LB Pharmaceuticals Inc
  1. Stock Market
  2. Stocks
  3. LBRX Stock
  4. Consensus LB Pharmaceuticals Inc